Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell ResMed Inc. (RMD) – ResMed Inc. Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ResMed (RMD) trades at $201.88, down 0.24% on the day, with strong fundamental performance including three consecutive quarterly earnings beats and robust revenue growth of 11% year-over-year in Q3 2026. The company maintains healthy profit margins with a 27.44% net income margin and positive cash flow generation. Analyst consensus remains favorable with a $294.50 price target, though technical indicators show bearish momentum with the stock trading near key support levels.
ResMed presents a compelling investment case with consistent earnings outperformance and strong financial health, though near-term technical weakness and competitive pressures in the medical device sector warrant caution. The stock offers 46% upside to analyst targets but faces headwinds from market volatility and execution risks in maintaining growth momentum.
Read full analysis

Key Stats

  • Market Cap
    $29.37B
  • Sector
    Health
  • 3M Drawdown
    -23.79%
  • Enterprise Value
    $28.55B
  • Dividend Yield
    1.19%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    62 days
$201.88
52W Low: $198.76
11 May 2026
52W High: $293.73
22 Aug 2025

ResMed Inc. (RMD) is currently valued at a market capitalization of $29.37B, with an enterprise value of $28.55B. Over the past 52 weeks, ResMed Inc. has traded between a low of $198.76 and a high of $293.73, highlighting its annual price range. Over the past three months, ResMed Inc. has recorded a drawdown of -23.79%, reflecting recent price volatility. ResMed Inc. offers a dividend yield of 1.19%, with the most recent dividend of $0.60 paid on 14 May 26. On average, investors hold ResMed Inc. for approximately 62 days, indicating typical investor behavior on the platform.

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.


Technical Indicators
|
|
|
Overall Summary
Bearish (11)Neutral (6)Bullish (10)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $29.37B
  • Sector
    Health
  • 3M Drawdown
    -23.79%
  • Enterprise Value
    $28.55B
  • Dividend Yield
    1.19%
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    62 days
$201.88
52W Low: $198.76
11 May 2026
52W High: $293.73
22 Aug 2025

ResMed Inc. (RMD) is currently valued at a market capitalization of $29.37B, with an enterprise value of $28.55B. Over the past 52 weeks, ResMed Inc. has traded between a low of $198.76 and a high of $293.73, highlighting its annual price range. Over the past three months, ResMed Inc. has recorded a drawdown of -23.79%, reflecting recent price volatility. ResMed Inc. offers a dividend yield of 1.19%, with the most recent dividend of $0.60 paid on 14 May 26. On average, investors hold ResMed Inc. for approximately 62 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!